Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2006 Aug;8(4):600-22.
doi: 10.1080/14622200600858166.

Biomarkers to assess the utility of potential reduced exposure tobacco products

Dorothy K Hatsukami  1 , Neal L Benowitz, Stephen I Rennard, Cheryl Oncken, Stephen S Hecht
Affiliations
Review

Biomarkers to assess the utility of potential reduced exposure tobacco products

Dorothy K Hatsukami et al. Nicotine Tob Res. 2006 Aug.

Abstract

To date, we have no valid biomarkers that serve as proxies for tobacco-related disease to test potential reduced exposure products. This paper represents the deliberations of four workgroups that focused on four tobacco-related heath outcomes: Cancer, nonmalignant pulmonary disease, cardiovascular disease, and fetal toxicity. The goal of these workgroups was to identify biomarkers that offer some promise as measures of exposure or toxicity and ultimately may serve as indicators for future disease risk. Recommendations were based on the relationship of the biomarker to what is known about mechanisms of tobacco-related pathogenesis, the extent to which the biomarker differs among smokers and nonsmokers, and the sensitivity of the biomarker to changes in smoking status. Other promising biomarkers were discussed. No existing biomarkers have been demonstrated to be predictive of tobacco-related disease, which highlights the importance and urgency of conducting research in this area.

PubMed Disclaimer

Corrected and republished from

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Agius RM, Rutman A, Knight RK, & Cole PJ (1986). Human pulmonary alveolar macrophages with smokers’ inclusions: Their relation to the cessation of cigarette smoking. British Journal of Experimental Pathology, 67, 407–413. - PMC - PubMed
    1. Ahlsten G, Cnattingius S, & Lindmark G (1993). Cessation of smoking during pregnancy improves foetal growth and reduces infant morbidity in the neonatal period. A population-based prospective study. Acta Paediatrica, 82, 177–181. - PubMed
    1. Ahlsten G, Ewald U, & Tuvemo T (1986). Maternal smoking reduces prostacyclin formation in human umbilical arteries. A study on strictly selected pregnancies. Acta Obstetrricia et Gynecologica Scandinavica, 65, 645–649. - PubMed
    1. Anthonisen N, Connett J, Kiley J, Altose M, Bailey W, Buist A, Conway WA Jr., Enright PL, Kanner RE, O’Hara P, Owens GR, Scanlon PD, Tashkin DP, & Wise RA (1994). Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1: The lung health study. The Journal of the American Medical Association, 272, 1497–1505. - PubMed
    1. Antonucci R, Contu P, Porcella A, Atzeni C, & Chiappe S (2004). Intrauterine smoke exposure: A new risk factor for bronchopulmonary dysplasia? Journal of Perinatal Medicine, 32, 272–277. - PubMed

Publication types